bevacizumab,atezolizumab
roche
['congrat', 'hcc']
 first positive adjuvant study in #hcc. os immature and likely will be difficult to show given cross over within the study. congrats to the investigators and teams for taking a step forward.
GI Medical Oncologist @CityofHope. Hepatobiliary & NET Cancers. Tweets are my own opinions. RTs are not endorsements.